Video Latest - ecancer

Targets for therapy in ETP-ALL

Prof Jan Cools - University of Leuven, Belgium

27 Jan 2017

The role of autologous transplant in ALL

Prof Sebastian Giebel - Silesian Medical University, Katowice, Poland

27 Jan 2017

Next steps for treating breast cancer

Dr Michel Velez - Memorial Healthcare System, Hollywood, FL, USA

6 Jan 2017

Epirubicin and cyclophosphamide before docetaxel in early breast cancer

Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark

14 Dec 2016

neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer

Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA

13 Dec 2016

PARP inhibitory velaparib trialled in BRCA1/2 breast cancer

Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA

13 Dec 2016

PD-1 therapy with eribulin for triple negative MBC

Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA

9 Dec 2016

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer

Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA

8 Dec 2016

Extended adjuvant endrocine therapy with letrozole after aromatase inhibition

Dr Terry Mamounas - UF Health Center, Orlando, USA

7 Dec 2016

Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma

Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA

6 Dec 2016

ASH 2016 highlights: breaking new ground in haematology

Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy

6 Dec 2016

ALL: Combining paediatric-type therapy with minimal residual disease

Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

5 Dec 2016

Video